1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. R1 RCM Inc.
  6. Summary
    RCM   US77634L1052

R1 RCM INC.

(RCM)
  Report
Real-time Estimate Cboe BZX  -  11:50 2022-08-18 am EDT
24.96 USD   -1.48%
08/15INSIDER SELL : R1 Rcm
MT
08/04Deutsche Bank Adjusts R1 RCM's Price Target to $31 From $26, Maintains Buy Rating
MT
08/03R1 RCM Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Nasdaq
08/11/2022 08/12/2022 08/15/2022 08/16/2022 08/17/2022 Date
25.63 25.78 26.18 25.33 25 Last
1048880 1374090 1541834 2209932 1593171 Volume
-1.61% +0.59% +1.55% -3.25% -1.30% Change
Estimated financial data (e) (USD)
Sales 2022 1 866 M - -
Net income 2022 102 M - -
Net Debt 2022 1 630 M - -
P/E ratio 2022 83,4x
Yield 2022 -
Sales 2023 2 447 M - -
Net income 2023 265 M - -
Net Debt 2023 1 364 M - -
P/E ratio 2023 37,7x
Yield 2023 -
Capitalization 10 402 M 10 402 M -
EV / Sales 2022 6,45x
EV / Sales 2023 4,81x
Nbr of Employees 21 400
Free-Float 62,4%
More Financials
Company
R1 RCM Holdco Inc., formerly R1 RCM Inc., is a provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers. Its services help healthcare providers generate sustainable improvements in their operating margins and cash flows while also improving patient, physician, and staff satisfaction for its customers. Its primary service offering consists of RCM... 
More about the company
Ratings of R1 RCM Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
D+
More Ratings
All news about R1 RCM INC.
08/15INSIDER SELL : R1 Rcm
MT
08/04Deutsche Bank Adjusts R1 RCM's Price Target to $31 From $26, Maintains Buy Rating
MT
08/03R1 RCM Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 3..
CI
08/03R1 RCM Swings to Loss in Q2, Reports Higher Revenue; Provides 2022 Outlook
MT
08/03TRANSCRIPT : R1 RCM Inc., Q2 2022 Earnings Call, Aug 03, 2022
CI
08/03R1 RCM Inc. Provides Revenue Guidance for the Full Year of 2022
CI
08/03R1 RCM Reports Second Quarter 2022 Results
AQ
08/01JPMorgan Reinstates R1 RCM at Overweight With $33 Price Target
MT
07/20R1 RCM to Release Second Quarter 2022 Results on August 3
AQ
07/15SECTOR UPDATE : Health Care Stock Adding to Friday Advance in Late Trade
MT
07/15R1 RCM to Provide Revenue Cycle Management Services for Sutter Health in 10-Year Agreem..
MT
07/15SECTOR UPDATE : Health Care Stocks Posting Strong Gains Friday
MT
07/15R1 RCM to Provide Revenue Cycle Management Services for Sutter Health in 10-Year Agreem..
MT
07/14R1 RCM Announces 10-Year End-to-End Revenue Cycle Management Partnership with Sutter He..
AQ
07/14R1 RCM Inc. Announces 10-Year End-To-End Revenue Cycle Management Partnership with Sutt..
CI
More news
News in other languages on R1 RCM INC.
08/03R1 RCM Inc. annonce ses résultats pour le deuxième trimestre et les six mois terminés l..
08/03R1 RCM subit une perte au deuxième trimestre, enregistre un revenu plus élevé et fourni..
08/03R1 RCM Inc. Fournit des prévisions de revenus pour l'année complète de 2022
07/15MISE À JOUR SECTORIELLE : Les actions du secteur de la santé ajoutent à la hausse de vendr..
07/15R1 RCM fournira des services de gestion du cycle des revenus à Sutter Health dans le ca..
More news
Analyst Recommendations on R1 RCM INC.
More recommendations
Chart R1 RCM INC.
Duration : Period :
R1 RCM Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends R1 RCM INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 25,00 $
Average target price 32,44 $
Spread / Average Target 29,8%
EPS Revisions
Managers and Directors
Joseph Gerard Flanagan Chief Executive Officer & Director
Lee Rivas President
Rachel Wilson Chief Financial Officer, Treasurer & Executive VP
Anthony J. Speranzo Chairman
Jay Sreedharan Chief Technology & Digital Officer, Executive VP
Sector and Competitors
1st jan.Capi. (M$)
R1 RCM INC.-0.63%10 402
CVS HEALTH CORPORATION1.71%137 742
HCA HEALTHCARE, INC.-18.66%59 985
LABORATORY CORPORATION OF AMERICA HOLDINGS-19.39%22 898
QUEST DIAGNOSTICS-20.33%16 073
REDE D'OR SÃO LUIZ S.A.-20.03%13 713